BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30954552)

  • 41. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
    Laskar RS; Ghosh SK; Talukdar FR
    Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.
    Ferracin M; Gafà R; Miotto E; Veronese A; Pultrone C; Sabbioni S; Lanza G; Negrini M
    J Pathol; 2008 Apr; 214(5):594-602. PubMed ID: 18241079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unique characteristics of CpG island methylator phenotype (CIMP) in a Chinese population with colorectal cancer.
    Liu J; Tang L; Yi J; Li G; Lu Y; Xu Y; Zhao S; Mao R; Li X; Ren L; Wang K
    BMC Gastroenterol; 2019 Nov; 19(1):173. PubMed ID: 31690257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
    Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Jun; 38(6):842-9. PubMed ID: 17350669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Apr; 38(4):585-92. PubMed ID: 17239930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas.
    Sun L; Guzzetta AA; Fu T; Chen J; Jeschke J; Kwak R; Vatapalli R; Baylin SB; Iacobuzio-Donahue CA; Wolfgang CL; Ahuja N
    Epigenetics; 2014 May; 9(5):738-46. PubMed ID: 24518818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.
    Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H
    Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype.
    Whitehall VL; Dumenil TD; McKeone DM; Bond CE; Bettington ML; Buttenshaw RL; Bowdler L; Montgomery GW; Wockner LF; Leggett BA
    Epigenetics; 2014 Nov; 9(11):1454-60. PubMed ID: 25496513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.
    Burnett-Hartman AN; Newcomb PA; Potter JD; Passarelli MN; Phipps AI; Wurscher MA; Grady WM; Zhu LC; Upton MP; Makar KW
    Cancer Res; 2013 May; 73(9):2863-72. PubMed ID: 23539450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
    Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
    Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes.
    Wang L; He X; Ugai T; Haruki K; Lo CH; Hang D; Akimoto N; Fujiyoshi K; Wang M; Fuchs CS; Meyerhardt JA; Zhang X; Wu K; Chan AT; Giovannucci EL; Ogino S; Song M
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of Aberrant Methylation in an Adjacent Area of Left-Sided Colorectal Cancer.
    Sambuudash O; Kim HS; Cho MY
    Yonsei Med J; 2017 Jul; 58(4):749-755. PubMed ID: 28540987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status.
    Dahlin AM; Palmqvist R; Henriksson ML; Jacobsson M; Eklöf V; Rutegård J; Oberg A; Van Guelpen BR
    Clin Cancer Res; 2010 Mar; 16(6):1845-55. PubMed ID: 20197478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic instability, CpG island methylator phenotype, and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum.
    Nando Y; Watari J; Ito C; Hara K; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Tomita T; Ohda Y; Oshima T; Fukui H; Matsubara N; Tomita N; Hirota S; Miwa H
    Hum Pathol; 2017 Feb; 60():37-45. PubMed ID: 27746269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.
    Lee MS; McGuffey EJ; Morris JS; Manyam G; Baladandayuthapani V; Wei W; Morris VK; Overman MJ; Maru DM; Jiang ZQ; Hamilton SR; Kopetz S
    Br J Cancer; 2016 Jun; 114(12):1352-61. PubMed ID: 27272216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses.
    Papadimitriou N; Qu C; Harrison TA; Bever AM; Martin RM; Tsilidis KK; Newcomb PA; Thibodeau SN; Newton CC; Um CY; Obón-Santacana M; Moreno V; Brenner H; Mandic M; Chang-Claude J; Hoffmeister M; Pellatt AJ; Schoen RE; Harlid S; Ogino S; Ugai T; Buchanan DD; Lynch BM; Gruber SB; Cao Y; Hsu L; Huyghe JR; Lin Y; Steinfelder RS; Sun W; Van Guelpen B; Zaidi SH; Toland AE; Berndt SI; Huang WY; Aglago EK; Drew DA; French AJ; Georgeson P; Giannakis M; Hullar M; Nowak JA; Thomas CE; Le Marchand L; Cheng I; Gallinger S; Jenkins MA; Gunter MJ; Campbell PT; Peters U; Song M; Phipps AI; Murphy N
    EBioMedicine; 2024 Mar; 101():105010. PubMed ID: 38350331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype.
    O'Brien MJ; Yang S; Clebanoff JL; Mulcahy E; Farraye FA; Amorosino M; Swan N
    Am J Surg Pathol; 2004 Apr; 28(4):423-34. PubMed ID: 15087661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.